vimarsana.com
Home
Live Updates
Galderma @ AAD 2024: New Data Demonstrate the Long-Term Efficacy of Nemolizumab in Prurigo Nodularis and Its Durability in Atopic Dermatitis : vimarsana.com
Galderma @ AAD 2024: New Data Demonstrate the Long-Term Efficacy of Nemolizumab in Prurigo Nodularis and Its Durability in Atopic Dermatitis : vimarsana.com
Galderma @ AAD 2024: New Data Demonstrate the Long-Term Efficacy of Nemolizumab in Prurigo Nodularis and Its Durability in Atopic Dermatitis
ZUG, Switzerland--(BUSINESS WIRE)--Mar 10, 2024--
Related Keywords
Japan ,
United States ,
Taiwan ,
American ,
Dermatol Venereol ,
Jessica Cohen ,
Emil Ivanov ,
Christian Marcoux ,
American Academy Of Dermatology Association ,
European Academy Of Dermatology ,
Corporate Communications ,
Chugai Pharmaceutical Co Ltd ,
Drug Administration ,
European Medicines Agency ,
Dermatology Association ,
Annual Meeting ,
Global Assessment ,
Dermatology Life Quality Index ,
Eczema Area ,
Severity Index ,
European Medicines ,
Injectable Aesthetics ,
Dermatological Skincare ,
Venereology European ,
Subjects With Moderate To Severe Atopic ,
Investor Relations ,
Business Wire ,
Business ,
Usiness ,